Ticelo Injection

Ticelo Injection contains nelarabine as its active ingredient and belongs to the antineoplastic agent class. It is used primarily in treating specific blood cancers, namely T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). The medication functions by interrupting cancer cell proliferation and causing cell death. As a chemotherapy agent, it is administered under rigorous medical supervision because of its potency and potential adverse effects. Before commencing treatment, patients require assessment of existing medical conditions, including hepatic and renal function, neurological status, and haematological parameters. It is contraindicated in individuals with severe neurological disorders or those with documented hypersensitivity to any component. Particular care must be exercised in pregnant and lactating women, as the drug may cause significant harm to the developing fetus or nursing infant. Patients must follow safety protocols to reduce adverse effects and achieve optimal therapeutic benefit.

Ticelo Injection is FDA-approved for the treatment of: T-cell acute lymphoblastic leukemia (T-ALL) T-cell lymphoblastic lymphoma (T-LBL)

This medication belongs to the class of antimetabolites and acts by interfering with DNA synthesis within rapidly dividing cancer cells. Once inside the body, it is converted into its active form, which integrates into the DNA of malignant cells, disrupting their ability to multiply. This ultimately leads to cell death and reduces the progression of the disease. Due to its targeted mechanism, it is highly effective in treating specific blood malignancies while requiring careful monitoring to manage its associated risks.

Common Side Effects: Fatigue Nausea and vomiting Decreased appetite Fever Muscle weakness Serious Side Effects: Severe bone marrow suppression Peripheral neuropathy (tingling, numbness, or weakness in limbs) Severe infections due to low white blood cell count Cognitive and coordination impairments Seizures (in rare cases)

Maintain regular follow-up appointments to monitor blood counts and overall health during treatment. Report any neurological symptoms such as confusion or muscle weakness to a healthcare provider immediately. Ensure adequate hydration to help reduce the risk of kidney-related side effects. Since the treatment can suppress immune function, avoid crowded places and limit exposure to potential infections. Incorporate supportive therapies and lifestyle modifications to improve tolerance and enhance overall treatment outcomes.